Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2006
06/22/2006WO2005044228A3 Compositions comprising cyclohexylamines and aminoadamantanes
06/22/2006WO2005041968A3 Once-a-day, oral, controlled-release, oxycodone dosage forms
06/22/2006US20060135640 Low peak exotherm curable compositions
06/22/2006US20060135625 Method of administering split doses of a vascular targeting agent
06/22/2006US20060135513 Methods of treating tumors
06/22/2006US20060135471 Anti-obesity compositions
06/22/2006US20060135469 Separate type medical material
06/22/2006US20060135464 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues
06/22/2006US20060135458 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses
06/22/2006US20060135449 A NF- kappa B decoy oligodeoxynucleotide of the sequence GGATTTCCC delivered in a liposome through the carotid artery; antiischemic agents, antitumor agents; analgesics, Alzheimer's Disease; gene transfection
06/22/2006US20060135407 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
06/22/2006US20060135402 in combination with oral delivery agent such as N-(5-chlorosalicyloyl)8-aminocaprylic acid (5-CNAC), N-10-[2-hydroxybenzoyl]aminodecanoic acid (SNAD) or N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC), or their disodium salts to improve bioavailability
06/22/2006US20060134785 Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same
06/22/2006US20060134422 active principle-based coated particle having a size 50-2 mm and comprising a core and a coating, each of which contains an active principle, wherein core consists of first active principle and coating consists of 60-99% by weight of second active principle different in nature from first; taste masking
06/22/2006US20060134282 Complex coacervate encapsulate comprising lipophilic core
06/22/2006US20060134223 Process for producing microparticles
06/22/2006US20060134222 Process for encapsulating an active lipid-soluble substance by preparing a pit emulsion and emulsion obtained
06/22/2006US20060134221 Methods for producing block copolymer/amphiphilic particles
06/22/2006US20060134220 Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof
06/22/2006US20060134219 Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
06/22/2006US20060134218 Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts
06/22/2006US20060134217 Leukotriene and integrin inhibitor combination and treatment method
06/22/2006US20060134216 Enteric film coating composition containing enteric polymer micronized with detackifier
06/22/2006US20060134215 Film coating composition, and coating and tablet of the composition
06/22/2006US20060134214 Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof
06/22/2006US20060134213 Stabilized ramipril compositions and methods of making
06/22/2006US20060134212 Lercanidipine immediate release compositions
06/22/2006US20060134211 Multi-layer drug delivery device and method of manufacturing same
06/22/2006US20060134210 Solid dosage form comprising proton pump inhibitor and suspension made thereof
06/22/2006US20060134209 Sustained-release nanoparticle compositions and methods for using the same
06/22/2006US20060134208 Controlled release and taste masking oral pharmaceutical composition
06/22/2006US20060134207 Dosage form containing diphenhydramine and another drug
06/22/2006US20060134206 Oral compositions for treatment of diseases
06/22/2006US20060134205 Process for preparing a pharmaceutical composition
06/22/2006US20060134204 Complexes made using low solubility drugs
06/22/2006US20060134203 a water insoluble drug (a cyclosporin or macrolides), a solubilizer, and a surfactant; improved stability, and bioavailability; immunosuppressants
06/22/2006US20060134202 Homeopathic sublingual dosage forms and methods thereof
06/22/2006US20060134201 Collagen troches for treating mouth lesions
06/22/2006US20060134200 Pharmaceutical composition based on agonist of benzodiazepine
06/22/2006US20060134199 Tablet quickly melting in oral cavity
06/22/2006US20060134198 Pharmaceutical compositions with improved dissolution
06/22/2006US20060134197 Method of reducing unpleasant taste and/or unpleasant odor
06/22/2006US20060134196 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
06/22/2006US20060134195 Mannose-based fast dissolving tablets
06/22/2006US20060134194 Formulations containing substituted imidazole derivatives
06/22/2006US20060134193 Method to improve pharmaceutical tablets having a matrix of cellulose ether
06/22/2006US20060134192 Method of stabilizing diarylvinylene compound
06/22/2006US20060134191 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
06/22/2006US20060134190 Formulations of bisphosphonate drugs with improved bioavailability
06/22/2006US20060134189 siRNA silencing of apolipoprotein B
06/22/2006US20060134188 Transdermal pharmaceutical preparation with a progesterone A-specific ligand (PRASL) as active ingredient
06/22/2006US20060134187 Method for treating inflammation associated with acne
06/22/2006US20060134186 Oxygenating agents for enhancing host responses to microbial infections
06/22/2006US20060134185 Self-adhesive reabsorbable hemostyptic
06/22/2006US20060134184 At least partially degradable films containing an active ingredient and method for the production of composition comprising an active compound
06/22/2006US20060134181 Novel chocolate composition as delivery system for nutrients and medications
06/22/2006US20060134167 Administering to the cardiac tissue an angiogenic thrombin derivative peptide and/or inhibiting vascular occulsion or restenosis and stimulating revascularization
06/22/2006US20060134164 Th2-inducing adjuvant treatment for osteolysis
06/22/2006US20060134161 Water-swellable polymers
06/22/2006US20060134151 Novel sulfamide derivatives and cosmetic use thereof
06/22/2006US20060134150 Submicron suspensions with polymorph control
06/22/2006US20060134149 Methods for treatment of inflammatory diseases
06/22/2006US20060134148 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
06/22/2006US20060134147 reducing the formation of cellulite in skin by topically applying to the skin a composition having a cosmetically acceptable vehicle and an effective amount of carnitine creatinate
06/22/2006US20060134146 pyrazine carboxamide compounds of sub-micron size; improve bioavailibility/absorption, exhibit no increase in size upon storage in the aqueous medium; N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide; using a precipitation process without the need for water-immiscible solvent; obesity
06/22/2006US20060134145 Propofol-containing fat emulsions
06/22/2006US20060134144 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof
06/22/2006US20060134140 Compositions and methods for treating tumor spreading
06/22/2006US20060134134 Method of obatining cochlear structures, vaccine compositions, adjuvants and interme- diates thereof
06/22/2006US20060134130 Oral drug delivery compositions and methods
06/22/2006US20060134101 Use of avian antibodies
06/22/2006US20060134085 Compositions containing coenzyme q10
06/22/2006US20060134070 Tissue regeneration
06/22/2006US20060134066 Localization of vectors and other agents
06/22/2006US20060134039 Nail restructuring compositions for topical application
06/22/2006US20060134010 Chemical composition and process
06/22/2006US20060134009 Low dose corticosteroid powders for inhalation
06/22/2006US20060134008 Compositions and methods for pulmonary conditions
06/22/2006US20060134007 Blister for inhalers
06/22/2006US20060134006 Chemical carrier based on a beta-limit dextrin
06/22/2006CA2593031A1 Compositions comprising polymeric emulsifiers and methods of using same
06/22/2006CA2591406A1 Pharmaceutical compounds and compositions
06/22/2006CA2591092A1 Temperature modulation of transdermal drug delivery
06/22/2006CA2590834A1 Compositons and methods for stabilizing active pharmaceutical ingredients
06/22/2006CA2590832A1 Formulations for production of capsule shells and capsules
06/22/2006CA2590696A1 Sustained delivery formulations of octreotide compounds
06/22/2006CA2590675A1 Nanoparticulate tacrolimus formulations
06/22/2006CA2589359A1 Targeted iron chelator delivery system
06/22/2006CA2588943A1 Medical tape preparation
06/22/2006CA2588042A1 Compositions and methods for pulmonary conditions
06/22/2006CA2586425A1 Enteric film coating composition containing enteric polymer micronized with detackifier
06/22/2006CA2585779A1 In-situ forming implant for animals
06/22/2006CA2530963A1 Phototherapy compositions and methods
06/22/2006CA2509083A1 A medical device
06/21/2006EP1672025A1 Finely particulate composite containing carbon compound encapsulated therein
06/21/2006EP1671965A2 Oxacarbocyclic oligomers of fumaric acid
06/21/2006EP1671942A1 Aerosol formulation comprising levalbuterol L-tartrate salt
06/21/2006EP1671660A1 Hot melt adhesives for medical application
06/21/2006EP1671655A1 Gene therapy for skin diseases using needle free syringe
06/21/2006EP1671651A1 Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists